Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jun 1;90(11):5162-6.
doi: 10.1073/pnas.90.11.5162.

Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor

Y A Kolesnikov  1 , C G Pick, G Ciszewska, G W Pasternak
Affiliations

Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor

Y A Kolesnikov et al. Proc Natl Acad Sci U S A. .

Abstract

The nitric oxide synthase inhibitor NG-nitro-L-arginine (NO2Arg) blocks morphine tolerance in mice. After implantation of morphine pellets the analgesic response decreases from 100% on the first day to 0% on the third. Coadministration of NO2Arg along with the pellets markedly retards the development of tolerance; 60% of mice are analgesic after 3 days, and 50% of mice are analgesic after 5 days. In a daily injection paradigm the analgesic response to morphine is reduced from 60% to 0% by 5 days. Concomitant administration of morphine along with NO2Arg at doses of 2 mg/kg per day prevents tolerance for 4 weeks. A single NO2Arg dose retards morphine tolerance for several days, and dosing every 4 days is almost as effective as daily NO2Arg. NO2Arg slowly reverses preexisting tolerance over 5 days despite the continued administration of morphine along with NO2Arg. NO2Arg also reduces dependence and reverses previously established dependence. NO2Arg does not prevent tolerance to analgesia mediated by the kappa 1 agonist trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolindinyl)cyclohexyl]- benzene-acetamide (U50,488H) or the kappa 3 agent naloxone benzoylhydrazone, indicating a selective action of NO in the mechanisms of mu tolerance and dependence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3092-6 - PubMed
    1. Eur J Pharmacol. 1992 Oct 20;221(2-3):399-400 - PubMed
    1. Eur J Pharmacol. 1978 Sep 15;51(2):185-6 - PubMed
    1. J Pharmacol Exp Ther. 1981 Aug;218(2):409-15 - PubMed
    1. Science. 1983 Jan 21;219(4582):310-2 - PubMed

Publication types

MeSH terms